UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Dec

    01

    Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS

    Oct

    18

    Evolving Expectations for Dermatological Conditions

    Oct

    17

    Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio

    Sep

    11

    UCB PharmD Second-Year Fellows Share Reflections and Advice

    Aug

    03

    Employee Spotlight: David Hornbaker’s Heart for Helping Patients

    Aug

    01

    Evolving Expectations for Dermatological Conditions

    Jun

    27

    Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

    Jun

    14

    How UCB Is Supporting the Mental Health of Patients and Caregivers

    Jun

    14

    Recognizing Ethical Leadership at UCB

    Jun

    02

    Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome